SCLStepan Company

$61.06+29% 1Y

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−2.7 points).

1 to watch, 1 neutral, 1 without data
Revenue trend+8% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.

Margin direction−2.7 points operating

Trailing-twelve-month operating margin, 0.7% now against 3.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 87% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is SCL growing?

Stepan Company has grown revenue −1.9% a year over three years and 3.1% a year over five, with earnings per share compounding at −32%.

−1.9%

Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+3.1%

Revenue growth, 5-year rate · −1.9% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−32%

Earnings per share, 3-year rate · revenue −1.9% · earnings lagged revenue: the growth is costing something

Years of annual history on file
17

Years of annual history on file · FY2009 to FY2025, as filed

Details›
Revenue FY2021
$2.35B
Revenue FY2022
$2.77B
Revenue FY2023
$2.33B
Revenue FY2024
$2.18B
Revenue FY2025
$2.33B

Annual income statements as filed with the SEC.